Trinity Biotech PLC. Daily Stock Analysis

Daily Stock Analysis, TRIB, Trinity Biotech PLC, priceseries

Trinity Biotech PLC. Daily Stock Analysis
Stock Information
Open
0.99
Close
0.94
High
1.02
Low
0.93
Previous Close
1.02
Daily Price Gain
-0.08
YTD High
1.52
YTD High Date
Jan 3, 2022
YTD Low
0.93
YTD Low Date
Mar 7, 2022
YTD Price Change
-0.49
YTD Gain
-34.38%
52 Week High
4.88
52 Week High Date
Mar 9, 2021
52 Week Low
0.93
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-3.07
52 Week Gain
-76.49%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Nov 12. 2018
3.25
Nov 14. 2018
3.47
2 Trading Days
6.77%
Link
LONG
Feb 19. 2019
2.67
Mar 7. 2019
3.05
12 Trading Days
14.37%
Link
LONG
Apr 5. 2019
2.87
Apr 9. 2019
3.03
2 Trading Days
5.55%
Link
LONG
Jul 8. 2019
1.79
Jul 19. 2019
2.24
9 Trading Days
25.29%
Link
LONG
Apr 9. 2020
0.93
May 6. 2020
1.48
18 Trading Days
59.46%
Link
LONG
Jul 2. 2020
2.29
Jul 13. 2020
2.50
6 Trading Days
9.17%
Link
LONG
Jul 14. 2020
2.54
Jul 24. 2020
2.72
8 Trading Days
6.96%
Link
LONG
Oct 7. 2020
2.14
Oct 21. 2020
2.54
10 Trading Days
18.48%
Link
LONG
Nov 13. 2020
3.02
Nov 17. 2020
3.21
2 Trading Days
6.29%
Link
LONG
Nov 23. 2020
3.54
Dec 11. 2020
4.11
13 Trading Days
16.13%
Link
LONG
Jan 29. 2021
4.77
Feb 17. 2021
6.07
12 Trading Days
27.23%
Link
LONG
May 20. 2021
3.28
May 25. 2021
3.47
3 Trading Days
5.79%
Link
LONG
Oct 7. 2021
2.25
Oct 8. 2021
2.38
1 Trading Days
5.56%
Link
Company Information
Stock Symbol
TRIB
Exchange
NasdaqGS
Company URL
http://www.trinitybiotech.com
Company Phone
01135312955111
CEO
Ronan O'Caoimh
Headquarters
-
Business Address
IDA BUSINESS PARK, BRAY, CO WICKLOW, IRELAND, DUBLIN IRELAND, IRELAND 18
Sector
Equity
Industry Category
Drugs
Industry Group
Diagnostic Substances
CIK
0000888721
About

Trinity Biotech Plc develops, manufactures and markets diagnostic test kits for the clinical laboratory. Its products are used to detect autoimmune, infectious and sexually transmitted diseases, autoimmune disorders, cardiac arrest, haemoglobin disorders, diabetes and disorders of the liver and intestine.The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Description

Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease, sexually transmitted diseases, respiratory infections, epstein barr virus, and other viral pathogens; and products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and Hb variants for the detection of Heamoglobinapothies. It also develops, manufactures, and distributes products in the immunofluorescence, enzyme-linked immunosorbent, western blot, and cytotoxicity assay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for detecting liver and kidney diseases, as well as haemolytic anaemia. In addition, the company offers Uni-Gold HIV, a POC diagnostic test, which is carried out in the presence of the patient to diagnose the presence of HIV antibodies. Further, it provides emergency medicine diagnostic tests; and sells raw materials to the life sciences industry and research institutes. Additionally, it offers Uni-Gold S. pneumoniae, Uni-Gold Legionella, Uni-Gold C. difficile, and Uni-Gold Syphilis products. The company sells its products through its direct sales force in the United States; and a network of independent distributors and strategic partners internationally. Its customers include public health facilities, hospitals, and other outreach facilities, as well as clinical and reference laboratories. Trinity Biotech plc was founded in 1992 and is headquartered in Bray, Ireland.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading